GREY:ATBPF - Post by User
Post by
themagicboxon Mar 31, 2022 12:53pm
218 Views
Post# 34563635
Otena still in the game
Otena still in the gameOn a more productive note, I found a very interesting drug for rheumatoid arthritis called baricitinib. Its getting traction in the news because of Jada smiths alopacia indicdent. https://en.wikipedia.org/wiki/Baricitinib
Anyway, this Eli lily drug got rejected by the FDA in April 2017 for "concerns about dosing and safety" but was approved a year later.
And in 2020 the FDA granted it "breakthrough therapy" designation to baricitinib for the treatment of alopecia.
When I reviewed the concenrs for dosing and safety, it was a some serious stuff. Hardly comparable to the Otenas elevated ALTs. Food for thought.
I am looking forward to seeing what happens with Otena in the next 2 years.